Literature DB >> 21403006

Progenitor cell-based treatment of the pediatric myelin disorders.

Steven A Goldman1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21403006      PMCID： PMC3358919          DOI： 10.1001/archneurol.2011.46

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  65 in total

1.  Towards the reconstruction of central nervous system white matter using neural precursor cells.

Authors:  M Mitome; H P Low; A van den Pol; J J Nunnari; M K Wolf; S Billings-Gagliardi; W J Schwartz
Journal:  Brain       Date:  2001-11       Impact factor: 13.501

2.  High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain.

Authors:  H M Keyoung; N S Roy; A Benraiss; A Louissaint; A Suzuki; M Hashimoto; W K Rashbaum; H Okano; S A Goldman
Journal:  Nat Biotechnol       Date:  2001-09       Impact factor: 54.908

3.  Isolation of multipotent neural precursors residing in the cortex of the adult human brain.

Authors:  Y Arsenijevic; J G Villemure; J F Brunet; J J Bloch; N Déglon; C Kostic; A Zurn; P Aebischer
Journal:  Exp Neurol       Date:  2001-07       Impact factor: 5.330

4.  Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain.

Authors:  Martha S Windrem; Neeta S Roy; Jeremy Wang; Marta Nunes; Abdellatif Benraiss; Robert Goodman; Guy M McKhann; Steven A Goldman
Journal:  J Neurosci Res       Date:  2002-09-15       Impact factor: 4.164

5.  Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

Authors:  Neeta S Roy; Carine Cleren; Shashi K Singh; Lichuan Yang; M Flint Beal; Steven A Goldman
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

6.  Hypoxia/ischemia depletes the rat perinatal subventricular zone of oligodendrocyte progenitors and neural stem cells.

Authors:  S W Levison; R P Rothstein; M J Romanko; M J Snyder; R L Meyers; S J Vannucci
Journal:  Dev Neurosci       Date:  2001       Impact factor: 2.984

7.  Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts.

Authors:  P A Leegwater; B Q Yuan; J van der Steen; J Mulders; A A Könst; P K Boor; V Mejaski-Bosnjak; S M van der Maarel; R R Frants; C B Oudejans; R B Schutgens; J C Pronk; M S van der Knaap
Journal:  Am J Hum Genet       Date:  2001-03-06       Impact factor: 11.025

Review 8.  Update on genetic disorders affecting white matter.

Authors:  E M Kaye
Journal:  Pediatr Neurol       Date:  2001-01       Impact factor: 3.372

9.  Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

Authors:  O N Koç; J Day; M Nieder; S L Gerson; H M Lazarus; W Krivit
Journal:  Bone Marrow Transplant       Date:  2002-08       Impact factor: 5.483

10.  Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse.

Authors:  Martha S Windrem; Steven J Schanz; Min Guo; Guo-Feng Tian; Vaughn Washco; Nancy Stanwood; Matthew Rasband; Neeta S Roy; Maiken Nedergaard; Leif A Havton; Su Wang; Steven A Goldman
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633
View more
  18 in total

Review 1.  Neural stem cell therapy for cancer.

Authors:  Juli Rodriguez Bagó; Kevin T Sheets; Shawn D Hingtgen
Journal:  Methods       Date:  2015-08-24       Impact factor: 3.608

Review 2.  Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.

Authors:  Ira J Fox; George Q Daley; Steven A Goldman; Johnny Huard; Timothy J Kamp; Massimo Trucco
Journal:  Science       Date:  2014-08-22       Impact factor: 47.728

Review 3.  Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease.

Authors:  M Joana Osorio; David H Rowitch; Paul Tesar; Marius Wernig; Martha S Windrem; Steven A Goldman
Journal:  Stem Cells       Date:  2016-11-23       Impact factor: 6.277

Review 4.  How to make an oligodendrocyte.

Authors:  Steven A Goldman; Nicholas J Kuypers
Journal:  Development       Date:  2015-12-01       Impact factor: 6.868

5.  Efficient Generation of Viral and Integration-Free Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes.

Authors:  Araceli Espinosa-Jeffrey; Bruno Blanchi; Juan Carlos Biancotti; Shalini Kumar; Megumi Hirose; Berhan Mandefro; Dodanim Talavera-Adame; Nissim Benvenisty; Jean de Vellis
Journal:  Curr Protoc Stem Cell Biol       Date:  2016-08-17

6.  Neurogenetics: Five new things.

Authors:  Suman Jayadev; Corrine O Smith; Thomas D Bird
Journal:  Neurol Clin Pract       Date:  2011-12

Review 7.  Glia Disease and Repair-Remyelination.

Authors:  Robin J M Franklin; Steven A Goldman
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-05-18       Impact factor: 10.005

8.  Glial-Restricted Precursors Protect Neonatal Brain Slices from Hypoxic-Ischemic Cell Death Without Direct Tissue Contact.

Authors:  Romy Sweda; Andre W Phillips; Joel Marx; Michael V Johnston; Mary Ann Wilson; Ali Fatemi
Journal:  Stem Cells Dev       Date:  2016-06-16       Impact factor: 3.272

Review 9.  Glial progenitor cell-based treatment and modeling of neurological disease.

Authors:  Steven A Goldman; Maiken Nedergaard; Martha S Windrem
Journal:  Science       Date:  2012-10-26       Impact factor: 47.728

Review 10.  Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.

Authors:  Steven A Goldman
Journal:  Cell Stem Cell       Date:  2016-02-04       Impact factor: 24.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.